NOVO NORDISK INC: efficacy supplement approved for AWIQLI FLEXTOUCH

NOVO NORDISK INC: efficacy supplement approved for AWIQLI FLEXTOUCH. Dated 12 days ago, it is in the active follow-up window. Score 75/100. As of 2026-11-04, from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration).

Data as of · Compiled by Zalwin from openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)

Free preview: all 7 published fields of this record are shown below. Locked: 499 related FdaApprovalPulse records and the 4-column CSV export.

FieldValue
SponsorNOVO NORDISK INC
ProductAWIQLI FLEXTOUCH
Generic / ingredientINSULIN ICODEC
ApprovalDrug efficacy supplement (new indication or use)
ApplicationBLA761326 supplement 1
Decided2026-10-23
Panel / classINJECTION, SOLUTION
Peer records CSV (500 records) 🔒 Click to unlock →
CRM-ready export with official source URLs 🔒 Click to unlock →

View the official record

Markdown version

Watch NOVO NORDISK INC

Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.

Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.

Unlock NOVO NORDISK + 500 peer records (CSV)

Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Product · Approval · Decided · official source URL

  • Source agency: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration)
  • Record date: 2026-10-23
  • Data refreshed: 2026-11-04
  • Refunds on request within 14 days

Search all records free →

Top FdaApprovalPulse records: Instylla, Inc. · Ventana Medical Systems, Inc. (Roche Tissue Diagnostics) · Cerenovus, Inc. · Advanced Medical Solutions Limited · Lenstec, Inc. · Browse all by state and category →

LIVE PUBLIC DATA Source: openFDA device PMA and Drugs@FDA endpoints (U.S. Food and Drug Administration) · Last refreshed: Wed, 04 Nov 2026 06:06:18 GMT

Is this your business? Add a "Listed on Zalwin" badge to your site

Paste this snippet into your website. It links to this public record; nothing is tracked on your site.

Listed on Zalwin badge preview

Search, filter and export more FdaApprovalPulse records

Run instant live search with these filters Download free sample CSV

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

75 / 100 Score

  • Decided in the last 30 days.
  • New indication or use: a relaunch.

What is the FdaApprovalPulse record for NOVO NORDISK INC?

The FDA approved AWIQLI FLEXTOUCH (BLA761326 supplement 1) for NOVO NORDISK INC on 2026-10-23: drug efficacy supplement (new indication or use).

How does NOVO NORDISK INC compare to other FdaApprovalPulse records?

It is fresh: dated 12 days ago, inside the window where early outreach matters most. Its Score of 75/100 puts it among the stronger signals in this feed.

NOVO NORDISK INC vs. top 3 peers

OrganizationRecord date
NOVO NORDISK INC2026-10-23
SUN PHARMA GLOBAL2026-10-29
PFIZER2026-10-26
PFIZER2026-10-26

Related records

FdaApprovalPulse: Drug efficacy supplement (new indication or use)

How to monitor NOVO NORDISK INC and peer drug efficacy supplement (new indication or use) records

Get new FdaApprovalPulse records like NOVO NORDISK INC by email (free, weekly)

We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.

Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.

See this week's digest

Get new approvals in your categories

FdaApprovalPulse emails new device and drug approvals matching your approval types.

See plans

✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days

From openFDA (PMA and Drugs@FDA). openFDA can lag FDA decisions by days to weeks. Drug supplement types follow the FDA submission class (labeling and REMS, manufacturing/CMC, efficacy, other). Company and product level only. Verify on FDA databases before relying on an approval.

Often used together